How do disease-modifying therapies function in the context of multiple sclerosis?

• A. They alleviate symptoms
• B. They repair myelin
• C. They alter the immune response
• D. They improve nerve conduction

Answer: (C)

Disease-modifying therapies for multiple sclerosis primarily function by altering the immune response. In multiple sclerosis, the immune system mistakenly attacks the myelin sheath that surrounds and protects nerve fibers, leading to inflammation and damage. The therapies are designed to modify the immune system's activity, reducing the frequency and severity of relapses and slowing the progression of the disease.

By targeting specific components of the immune system, these therapies can help reduce inflammatory responses, decrease the number of lesions in the central nervous system, and ultimately preserve neurological function over time. This immunomodulatory approach is crucial in managing the disease's course and improving long-term outcomes for patients.

Other options, such as alleviating symptoms or improving nerve conduction, do not directly address the root causes of MS. They may play a role in the overall management of the disease but do not modify its progression or the immune dynamics that contribute to its pathology. Similarly, while some therapies may support myelin repair indirectly over the long term, their primary function is to alter the immune response rather than repair existing damage.